Cboe Global to exit Japan equities operations
The company expects to suspend operations on August 29, 2025, and formally close the business after consultations with regulators.
The decision was made in response to evolving business conditions that challenged the financial sustainability of maintaining its equities operations in Japan.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
12 minutes ago
- Yahoo
SergeFerrari Group: Revenue of €178.7 Million in the First Half of 2025
Continued sales momentum in the 2nd quarter of 2025 Growth exceeds 10% in the first six months of 2025 SAINT-JEAN-DE-SOUDAIN, France, July 29, 2025--(BUSINESS WIRE)--Regulatory News: SergeFerrari Group (FR0011950682 – SEFER), SergeFerrari Group (FR0011950682 - SEFER), a leading global supplier of innovative flexible composite materials, listed on Euronext Paris – Compartment C, today announced its revenues for the first half of 2025. Breakdown of sales by geographic area (unaudited) (€ thousands) 2ndquarter2025 2ndquarter2024 Ch. atcurrentscope andexchangesrates Ch. atconstantscope andexchangesrates H1 2025 H1 2024 Ch. atcurrentscope andexchangesrates Ch. atconstantscope andexchangesrates Europe 69,068 66,730 +3.5% +3.2% 128,589 120,519 +6.7% +6.5% Americas 14,979 8,325 +79.9% +86.4% 23,399 16,003 +46.2% +48.7% Asia – Africa – Pacific 15,512 13,387 +15.9% +16.0% 26,743 25,382 +5.4% +5.4% Total revenues 99,558 88,442 +12.6% +13.0% 178,731 161,904 +10.4% +10.5% Sébastien Baril, SergeFerrari Group's chairman of the Executive Board, stated: "Signs of improvement in our historic markets are gradually materializing. Serge Ferrari recorded an increase in revenues of over 10% in the first half of the year. This performance encourages us to continue our efforts to increase our operating leverage, our customer service and the flexibility of our cost structure in an environment where adaptability and responsiveness remain key." Q2 2025 activity The Group reported revenue of €99.6 million in the 2nd quarter of 2025, up 12.6% on a current scope and exchange rate basis, and up 13.0% on a constant scope and exchange rate basis compared with the same period last year. This change is due to: A currency effect of -0.4 %; A volume effect of -3.0%, due mainly to a fall in volumes of modular structures, for which the end markets are declining; A favorable price-mix effect of +16.0%, driven by a confirmed recovery in activities that have traditionally been profitable for the Group, such as Solar Protection and the new Solutions business lines, as well as the impact of price increases introduced to mitigate the negative effect of high inflation on certain raw materials. H1 2025 activity The Group posted sales of €178.7 million in the first half of 2025, up by more than 10% on both current and constant scopes and exchange rates. Half-year sales trends by geographical region are as follows: Europe posted solid revenue growth of 6.7% on a current scope and exchange rate basis and 6.5% on a constant scope and exchange rate basis, with sales of almost €129 million over the period, thanks to historic markets that remain well oriented. After a difficult 2024 exercise in North American markets, sales in the Americas rebounded strongly in the first half. Growth accelerated sharply between the 1st and 2nd quarters, taking half-year sales up to €23.4 million, representing growth at constant scope and exchanges rates of +49%. Sales in the Asia-Africa-Pacific region were up 5.4% on H1 2024, both on a current and constant scope and exchange rates basis, due to good momentum in the various markets. Outlook Based on a seasonal history between the first (driven by solar protection activity and tense architecture) and the second half of the fiscal year, the group will focus (despite an uncertain context, particularly on the geopolitical level) on maintaining its trajectory initiated with Transform 2025 that aims at increasing its adaptability and profitability. Financier calendar Publication of first half 2025 results on September 10, 2025, after market close. ABOUT SERGEFERRARI GROUP The Serge Ferrari Group is a leading global supplier of composite materials for Tensile Architecture, Modular Structures, Solar Protection and Furniture/Marine, in a global market estimated by the Company at around €6 billion. The unique characteristics of these products enable applications that meet the major technical and societal challenges: energy-efficient buildings, energy management, performance and durability of materials, concern for comfort and safety together, opening up of interior living spaces etc. Its main competitive advantage is based on the implementation of differentiating proprietary technologies and know-how. The Group has manufacturing facilities in France, Switzerland, Germany, Italy and Asia. Serge Ferrari operates in 80 countries via subsidiaries, sales offices and a worldwide network of over 100 independent distributors. At the end of 2024, SergeFerrari Group posted consolidated revenues of €323.6 million, more than 80% of which was generated outside France. SergeFerrari Group is listed on Euronext Paris – Compartment C (ISIN code: FR0011950682). SergeFerrari Group shares are eligible for the PEA-PME and FCPI investment schemes. View source version on Contacts Valentin Chefson Head of Relations Investisseursinvestor@ NewCap Investor Relations – Financial Communication Théo MartinTel. : 01 44 71 94 94sferrari@
Hamilton Spectator
40 minutes ago
- Hamilton Spectator
VERSES® Shareholder Update Letter
VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ('VERSES'' or the 'Company'), a cognitive computing company specializing in next-generation agentic software systems releases a shareholder letter ahead of the corporate webinar today, Tuesday June 29th at 9:30am PT/12:30pm ET. Shareholder Update Summer 2025 Thank you to all of our investors and stakeholders who have supported us during the last few years, and especially during the most recent challenging times. We are hosting a webinar today and look forward to discussing these points in more detail and we encourage you to join us using this link: Here We are at day 1 of AI When we founded VERSES we were excited by the possibilities that AI and Spatial Computing offered to make the world smarter and better and we have been working hard to try to make that vision a reality. While some types of AI have become mainstream seemingly overnight, in our view, Enterprise AI adoption has, so far, been slow, especially for important tasks such as running a business, driving a car or logistics. In our view, slower than expected adoption isn't because of a lack of interest from large companies, but rather it is because Large Language Models (LLMs), while an incredible achievement, do not really perform tasks and are not reliable for many purposes. VERSES approach is based in science We believe our strategy is different and unique from other AI companies, so it's natural that many people still need to understand the full scope and application of what we are developing here at VERSES. We drew inspiration from human intelligence for a simple reason. Evolution has invested millions of years into brains and bodies that are efficient at thriving in our world. That's why, for example, a human brain operates on only 20 Watts. And it is why we can quickly adapt to a changing environment. Karl Friston, often listed as one of the world's most cited neuroscientist, is our Chief Scientist. He and others have, over the last few decades, described this process as 'active inference'. The brain models the world and checks it against what it senses. To do this, the brain runs experiments. It assesses how well its model works. Then, it tests this model in the real world. Based on the results, it decides whether to keep the current model or update it to better match reality. This process has been validated in multiple examples in numerous peer-reviewed journals demonstrating how actual neurons perform this process1, but people have generally believed these approaches are impossible to translate to computer science at a scalable level. Proof that it's working: Proof #1: AXIOM We recently unveiled what we believe is the world's first digital brain, AXIOM . AXIOM has different modules for vision, memory, prediction and reasoning. These then recombine to work together to sense, reason, plan, act and learn. In benchmarking, we have determined that AXIOM is more reliable and dramatically more efficient than other top models. Proof #2: Spatial Web Brains don't just make models - they test them in the physical world. That's why we led the process to establish the new Spatial Web standards. which we believe will allow AI agents to work together to solve problems, safely and securely. Proof #3: Customers This approach isn't theoretical - since the end of April we have started to sell it to enterprise customers through our product Genius ™. On use cases, we believe that our customers find Genius particularly useful where the data is uncertain, missing or volatile, and where they need a reliable and efficient solution. We recently announced that a large global financial institution signed an enterprise agreement to model financial markets. And we announced results of our pilot with Analog to optimize fleet management, which was estimated to create up to 32% better performance We believe smart cities can benefit from Genius, whether it's optimally managing autonomous cars, sensors, drones and robotics, or energy in the smart grid. Proof #4: Recognition We are increasingly recognized by journalists and mainstream media. WIRED called VERSES ' A Deep Learning Alternative Can Help AI Agents Gameplay the Real World '. In that feature, François Chollet, creator of the ARC-AGI benchmark, told WIRED that 'The general goals of the [VERSES] approach and some of its key features track with what I see as the most important problems to focus on to get to AGI… The work strikes me as very original.' What's the next big thing? We've shared with you how our technology can be applied to data problems, but one of the emerging frontiers, is robotics. We encourage you to view an important video from our robotics team showing some early progress powering robots that can perform challenging tasks in real world scenarios, without training. You can view the video here: . Robots typically struggle to tackle challenges such as unanticipated objects in their way or a challenge not in their training data. Our approach promises to tackle this - and we expect to publish more information soon. Thank you, VERSES Team About VERSES VERSES® is a cognitive computing company building next-generation intelligent software systems modeled after the wisdom and genius of Nature. Designed around first principles found in science, physics and biology, our flagship product, Genius™, is an agentic enterprise intelligence platform designed to generate reliable domain-specific predictions and decisions under uncertainty. Imagine a Smarter World that elevates human potential through technology inspired by Nature. Learn more at , LinkedIn and X . On behalf of the Company Gabriel René, Founder & CEO, VERSES AI Inc. Press Inquiries: press@ Investor Relations Inquiries James Christodoulou, Chief Financial Officer IR@ , +1(212)970-8889 Cautionary Note Regarding Forward-Looking Statements This news release contains statements which constitute 'forward-looking information' or 'forward-looking statements' within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of the Company with respect to future business activities and plans of the Company. Forward-looking information and forward-looking statements are often identified by the words 'may', 'would', 'could', 'should', 'will', 'intend', 'plan', 'anticipate', 'believe', 'estimate', 'expect' or similar expressions. The forward–looking statements and information are based on certain key expectations and assumptions made by the management of the Company. As a result, there can be no assurance that such plans will be completed as proposed or at all. Such forward-looking statements are based on a number of assumptions of management. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward–looking statements and information since no assurance can be given that they will prove to be correct. Forward-looking statements and information are provided for the purpose of providing information about the current expectations and plans of management of the Company relating to the future. Readers are cautioned that reliance on such statements and information may not be appropriate for other purposes, such as making investment decisions. Since forward–looking statements and information address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Accordingly, readers should not place undue reliance on the forward–looking statements and information contained in this news release. Readers are cautioned that the foregoing list of factors is not exhaustive. The forward–looking statements and information contained in this news release are made as of the date hereof and no undertaking is given to update publicly or revise any forward–looking statements or information, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement. 1 For instance Canonical neural networks perform active inference
Yahoo
3 hours ago
- Yahoo
Esperion Therapeutics (ESPR) Gets Boost from Acquisition Rumors
We recently published . Esperion Therapeutics, Inc. (NASDAQ:ESPR) is one of the best-performing stocks on Monday. Esperion Therapeutics extended its winning streak to a fifth consecutive day on Monday, adding 5.3 percent to close at $1.59 apiece as investors gobbled up shares ahead of its earnings release amid reports that it was set to be acquired by a Japan-based pharmaceutical company. According to a post by @rumourbuyouts on X, pharmaceutical firm Otsuka is said to be in talks to fully acquire Esperion Therapeutics, Inc. (NASDAQ:ESPR) in a deal that could potentially be valued $900 million. The post added that the two companies are set to meet in August to discuss a deal. Copyright: lightwise / 123RF Stock Photo Based on the social media handle, @rumourbuyouts is currently based in Japan and only has 177 followers. Meanwhile, Esperion Therapeutics, Inc. (NASDAQ:ESPR) said that it is scheduled to release the results of its second quarter earnings performance before market open on August 5, Tuesday. While we acknowledge the potential of ESPR as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
